XRAY vs COO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

XRAY

59.3
AI Score
VS
XRAY Wins

COO

48.6
AI Score

Investment Advisor Scores

XRAY

59score
Recommendation
STRONG BUY

COO

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY COO Winner
Forward P/E 6.3291 11.3379 XRAY
PEG Ratio 0.633 0.5198 COO
Revenue Growth -4.1% 0.6% COO
Earnings Growth 15.2% 357.1% COO
Tradestie Score 59.3/100 48.6/100 XRAY
Profit Margin -15.0% 13.5% COO
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD XRAY

Relative Price Performance (Last 90 Days)

XRAY 1M: -2.9% · 3M: -26.5% COO 1M: +10.0% · 3M: -12.3%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.1 · Price: $9.50

COO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.3 · Price: $61.65

Fundamentals Snapshot

Metric XRAY COO
Market Cap — —
Forward P/E 6.4 13.1
Trailing P/E — 20.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.5% 0.7%
Operating Margin 0.1% 0.2%
EPS -2.73 2.91
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.